Condition

Breast Ductal Carcinoma In Situ

ClinicalTrials.gov condition label

Clinical trials24

Recruiting7

Common interventions25

Lead sponsors shown10

Clinical trials

24 shown

A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast DuctsNCT07339306 · 2026-01-01

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk ReductionNCT06195306 · 2025-07-28

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast CancerNCT05941520 · 2024-10-10

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE TrialNCT06184750 · 2024-09-27

Identifying and Caring for Individuals With Inherited Cancer SyndromeNCT04494945 · 2020-03-09

A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In SituNCT04144023 · 2019-06-27

Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast SurgeryNCT04169542 · 2019-05-21

Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialNCT06671912 · 2025-02-19

Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT TrialNCT06617455 · 2024-10-31

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast CancerNCT06538389 · 2024-08-26

Metformin and Nightly Fasting in Women With Early Breast CancerNCT05023967 · 2023-04-04

ACTIVE_NOT_RECRUITING

Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID StudyNCT05545150 · 2022-11-28

Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast CancerNCT05340673 · 2022-09-09

ACTIVE_NOT_RECRUITING

An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer SurvivorsNCT05012176 · 2021-11-01

EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast CancerNCT05086705 · 2020-10-07

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast CancerNCT03979508 · 2020-01-10

Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast CancerNCT04022772 · 2019-07-31

Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast SurgeryNCT03317405 · 2018-10-31

ACTIVE_NOT_RECRUITING

Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast CancerNCT03323658 · 2018-06-15

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast CancerNCT02876640 · 2018-03-16

Breast Cancer WEight Loss Study (BWEL Study)NCT02750826 · 2016-09-16

ACTIVE_NOT_RECRUITING

Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast CancerNCT02636582 · 2016-06-14

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerNCT01272037 · 2011-02-28

ACTIVE_NOT_RECRUITING

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone LumpectomyNCT00769379 · 2008-12-10

Common interventions

Leading sponsors

National Cancer Institute (NCI)9 M.D. Anderson Cancer Center3 Alliance for Clinical Trials in Oncology2 City of Hope Medical Center2 Mayo Clinic2 Ohio State University Comprehensive Cancer Center2 Northwestern University1 OHSU Knight Cancer Institute1 The Fourth Affiliated Hospital of China Medical University1 University of Michigan Rogel Cancer Center1

Trial status mix

COMPLETED7

RECRUITING7

ACTIVE_NOT_RECRUITING5

TERMINATED3

SUSPENDED2

Phase mix

PHASE29

NA5

PHASE15

PHASE34

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.